Applied Clinical Trials
August 01, 2004
View from Washington
New standards and research methods aim to provide more useful information on population subgroups.
August 01, 2004
View from Brussels
Dismay over the level of anti-pharma feeling in the EU is not just "crying wolf."
August 01, 2004
Process Improvement
Move away from the "service" model if it means being subservient.
August 01, 2004
Letters to the Editor
Readers respond to articles and columnists.
August 01, 2004
Feature Article
Long overlooked as global drug innovators, Japanese pharmaceutical companies are gaining attention for their novel clinical development programs.
August 01, 2004
Feature Article
Well-planned studies designed to pinpoint additional data are increasingly important as a result of the EU's emphasis on added therapeutic value.
August 01, 2004
Feature Article
A new, standard-based approach minimizes the delays between discovery of innovative agents and identification of their therapeutic benefit for patients-critical in cancer research.
August 01, 2004
News
Arthur L. Caplan, Ph.D., chair of the University of Pennsylvania's Department of Medical Ethics, expressed his frank views about issues that are ailing the drug industry today during his DIA Keynote Address in mid-June.